Table 1.
Patient-based variable | Total cohort (n = 274) a |
---|---|
Age, y, mean (SD) | 50.0 (16.5) |
Body mass index, kg/m2, median (IQR) | 26.9 (23.7-30.4) |
Distressed Communities Index, median (IQR) | 23.7 (9.9-46.6) |
Female sex, No. (%) | 109 (39.8) |
Race, No. (%) | |
American Indian or Alaska Native | 2 (0.8) |
Asian | 5 (1.9) |
Black or African American | 25 (9.6) |
Hispanic | 8 (3.1) |
White | 220 (84.6) |
English-speaking, No. (%) | 265 (97.1) |
Comorbidities, No. (%) | |
Depression | 74 (27.0) |
Anxiety | 67 (24.5) |
Diabetes mellitus | 34 (12.4) |
Fibromyalgia | 12 (4.4) |
Current smoker, No. (%) | 37 (13.6) |
Dominant upper extremity affected, No. (%) | 151 (57.2) |
Chronic opioid use, No. (%) | 18 (6.6) |
Chronic pain, No. (%) | 30 (11.0) |
Recent opioid prescription, No. (%) | 33 (12.1) |
Note. SD = standard deviation; IQR = interquartile range.
Data were missing for the following explanatory variables (n = number of patients with available data): body mass index (n = 273), race (n = 260), language (n = 273), smoking status (n = 273), upper extremity dominance (n = 264), chronic opioid use (n = 273), recent opioid prescription (n = 273), chronic pain (n = 272).